Affiliation:
1. The Seventh People’s Hospital, Shanghai University of Traditional Chinese Medicine , 358 Datong Road, Pudong, Shanghai 200137 , China
Abstract
Abstract
Objectives
To illustrate the metabolic regulatory mechanisms of Jiangzhi decoction (JZD) against non-alcoholic fatty liver disease (NAFLD).
Methods
High-fat diet (HFD)-induced NAFLD rats were treated with JZD. The pathological morphology, lipid indexes and liver function were detected. Metabolic profiles were examined by liquid chromatography–mass spectrometry (LC–MS). Multivariate and univariate statistical analysis were used to search the differential metabolites. Pathway enrichment analysis was carried out using Kyoto Encyclopedia of Genes and Genomes database. Compound-gene networks were built by Cytoscape software.
Results
JZD significantly alleviated the pathological conditions and improved lipid index levels. Multivariate analysis showed a good separation among different groups. Three hundred and twenty-seven metabolites in HFD versus control and 301 metabolites in JZD versus HFD were identified to be significantly different. Pathway enrichment analysis showed that lipid metabolism pathways were prominent altered pathways. Importantly, the relationships were more distant between JZD and HFD groups in all five lipid metabolism pathways, including arachidonic acid metabolism, linoleic acid metabolism, biosynthesis of unsaturated fatty acids, glycerophospholipid metabolism and sphingolipid metabolism, while those were obviously closer between JZD and control groups. Simultaneously, JZD treatment restored the levels of disturbed differential metabolites in HFD group.
Conclusion
JZD had an effect on alleviating NAFLD via regulating relevant lipid metabolism.
Funder
National Natural Science Foundation of China
Shanghai Municipal Health Commission
Talents Training Program of Pudong Health Commission of Shanghai
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference61 articles.
1. Current treatment of non-alcoholic fatty liver disease;Paternostro,2022
2. Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world;Henry;Aliment Pharmacol Ther,2022
3. Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment;Yang,2020
4. Treating 98 cases of hyperlipidemia with Jiangzhi decoction;Lu;China Healthc Front,2009
5. Treating 196 cases of hyperlipidemia with Jiangzhi decoction;Huang;Zhejiang J Tradit Chin Med,2011
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献